Indaptus Therapeutics, Inc.: Form 8-K, filed May 25, 2023
Filed with the SEC on May 25, 2023 and accepted by EDGAR at May 25, 2023, 16:05 ET.
Items reported
- Item 5.07 Shareholder vote results
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001493152-23-019073. Last ingested by Listed: Nov 14, 2026, 21:10 ET. Listed shows no prices and gives no investment advice.